The role of SF3B1 and NOTCH1 in the pathogenesis of leukemia.

Abolhasani, Shiva; Hejazian, Seyyed Sina; Karpisheh, Vahid; Khodakarami, Atefeh; Mohammadi, Hamed; Gholizadeh Navashenaq, Jamshid; Hojjat-Farsangi, Mohammad; Jadidi-Niaragh, Farhad

Abolhasani, Shiva; Hejazian, Seyyed Sina; Karpisheh, Vahid; Khodakarami, Atefeh; Mohammadi, Hamed; Gholizadeh Navashenaq, Jamshid; Hojjat-Farsangi, Mohammad; Jadidi-Niaragh, Farhad.

Afiliación

Abolhasani S; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Hejazian SS; Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran.
Karpisheh V; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Khodakarami A; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Mohammadi H; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Gholizadeh Navashenaq J; Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Hojjat-Farsangi M; Non-communicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
Jadidi-Niaragh F; Bioclinicum, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.

IUBMB Life ; 75(3): 257-278, 2023 03.

Article en En | MEDLINE | ID: mdl-35848163

Asunto(s)

Leucemia; Factores de Transcripción; Humanos; Leucemia/fisiopatología; Mutación; Factores de Transcripción/genética; Factores de Transcripción/metabolismo

Palabras clave

NOTCH1; SF3B1; leukemia; targeted therapy; therapeutic resistance

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Leucemia Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: IUBMB Life Asunto de la revista: BIOLOGIA MOLECULAR / BIOQUIMICA Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google